title: [Myelography conducted on an outpatient basis (author's transl)].
abstract: The introduction of the non-ionogenic product metrizamide made lumbosacral myelography a low-risk, invasive diagnostic procedure. Examination carried out on an outpatient basis does not involve greater risks or side effects than examination on an inpatient basis. However, it is essential that--apart from informing the patient properly--the patient shows discipline and remains available for the examining physician during a period of 36 hours.
mesh_terms: D000553:Ambulatory Care; D005260:Female; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000000981:diagnostic imaging; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging; D008297:Male; D008793:Metrizamide; D009192:Myelography / Q000009:adverse effects / Q000379:methods*; D010349:Patient Compliance
chemical_list: D008793:Metrizamide
vernacular_title: Die ambulant durchgeführte Myelographie.